Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Julian Baker | M | 57 | 9 years | |
| Elizabeth Garofalo | M | 66 | 4 years | |
| Katherine Bishop | M | 58 | 3 years | |
| James Daly | M | 63 | 8 years | |
| Christine Cvijic | F | 46 |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | 5 years |
| Julie Fisher | F | - | 6 years | |
| Christine Mikail, | - | - |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | 5 years |
| Edmund Harrigan | M | 71 | 9 years | |
| Mark Schneyer | M | 50 | 4 years | |
| Brendan Teehan | M | 56 | 6 years | |
| Sanjeev Pathak | M | - | 3 years | |
| Holly Valdiviez | F | - | 2 years | |
| Adora Ndu | M | 43 | 2 years | |
| Parag V. Meswani | M | - | 2 years | |
| James Kihara | M | - | 4 years | |
| Ponni Subbiah | M | - | 5 years | |
| Peter Norman | M | - | 11 years | |
| Sukumar Nagendran | M | 58 |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | 5 years |
| Robert Baffi | M | 68 |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | 4 years |
| Benir Ruano | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Elena Ridloff | F | 44 | 3 years | |
| Eric Floyd | M | 62 |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY.
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | - |
| William H. Koster | M | 79 |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | 7 years |
| Les Kaplan | M | 73 | 18 years | |
| Amanda Morgan | F | - | - | |
| Jorge A. Quiroz | M | 55 |
Johnson & Johnson Pharmaceutical Research & Development LLC
 Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ. | 4 years |
| Todd Young | M | 52 | 2 years | |
| Allan Grant Oberman | M | 66 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | 2 years |
| Bryan Reasons | M | 56 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 6 years |
| Jacob M. Plotsker | M | 56 |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | 3 years |
| Kevin E. Moley | M | 77 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | - |
| John Dawson | M | 64 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 11 years |
| Eric Siegel | M | 60 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 3 years |
| Glenn F. Baity | M | 54 | 14 years | |
| Austin Kim | M | 60 | 6 years | |
| Torsten Erik Rasmussen | M | 78 | 17 years | |
| Leith Martin | M | - |
The University of Alabama
| 7 years |
| Peter J. Zimetbaum | M | 60 | - | |
| William McDowall Wells | M | 63 | 4 years | |
| Mary Gray | M | 71 | 11 years | |
| Gerri Henwood | F | 71 | 4 years | |
| Leslie L. Iversen | M | 86 | 18 years | |
| Mark B. Skaletsky | M | 75 | - | |
| Michael T. Borer | M | 65 | 11 years | |
| Dragan Kovacevic | M | 68 |
University of Belgrade
| 4 years |
| Eric S. Purple | M | - |
The University of Alabama
| 3 years |
| Miodrag Tancic | M | 64 |
University of Belgrade
| 4 years |
| Stojan Colakov | M | 67 |
University of Belgrade
| 4 years |
| Bryan Keith White | M | - |
The University of Alabama
| 1 years |
| Christopher Flint | M | - |
The University of Alabama
| 3 years |
| Brent Akers | M | - |
The University of Alabama
| 4 years |
| Ljubinka V. Rajakovic | M | - |
University of Belgrade
| 1 years |
| Randy Modlin | M | - |
The University of Alabama
| 4 years |
| Ranko Vujosevic | M | - |
University of Belgrade
| 4 years |
| Stanisavlevich Neboysha | M | 65 |
University of Belgrade
| 4 years |
| Miroljub Hadžic | M | 66 |
University of Belgrade
| 4 years |
| Zoran Stojkovic | M | 70 |
University of Belgrade
| 3 years |
| Jason Harris | M | - |
The University of Alabama
| 4 years |
| Jason Polancich | M | - |
The University of Alabama
| 4 years |
| Vivek Ramana | M | 65 |
University of Belgrade
| 3 years |
| Bradley Gray | M | 56 |
The University of Alabama
| 4 years |
| Radomir Radicevic | M | - |
University of Belgrade
| 4 years |
| Lesley Russell | M | 63 |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | 1 years |
| Milena Topolac Tomovic | F | 66 |
University of Belgrade
| 4 years |
| Gyeong-Seon Son | M | 60 |
The University of Alabama
| 4 years |
| Biljana Bukic | F | - |
University of Belgrade
| 3 years |
| Chi Shing Li | M | 67 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | - |
| Bogdan Uzelac | M | 70 |
University of Belgrade
| 4 years |
| Dragan Grujicic | M | 63 |
University of Belgrade
| 4 years |
| Slavica Glišic | F | 70 |
University of Belgrade
| 4 years |
| Tom Lofton | M | - |
The University of Alabama
| 2 years |
| Dejan Ilic | M | 67 |
University of Belgrade
| 4 years |
| Michael J. Edgell | M | - |
The University of Alabama
| 4 years |
| Hewes Hull | M | - |
The University of Alabama
| 4 years |
| Russell T. Henshaw | M | - |
The University of Alabama
| 4 years |
| Radoje Drmanac | M | 66 |
University of Belgrade
| 4 years |
| Cüneyt Demirgüres | M | 59 |
The University of Alabama
| 3 years |
| Shonna W. Felkel | F | - |
The University of Alabama
| 3 years |
| Tammy Halcomb | F | - |
The University of Alabama
| 4 years |
| Hunt Bryan | M | - |
The University of Alabama
| 4 years |
| John Cassimus | M | - |
The University of Alabama
| 4 years |
| Matthew D. Anderson | M | - |
The University of Alabama
| 4 years |
| Dean Dillard | M | - |
The University of Alabama
| 4 years |
| Duncan Williams | M | 56 |
The University of Alabama
| 4 years |
| Nash Popovic | M | - |
University of Belgrade
| 7 years |
| Richard W. Rodgers | M | - |
The University of Alabama
| 4 years |
| Mark Farbman | M | - |
The University of Alabama
| 4 years |
| Tommy Thompson | M | - |
The University of Alabama
| 4 years |
| Bill Lorimer | M | - |
The University of Alabama
| 4 years |
| Samir Shah | M | - |
The University of Alabama
| 2 years |
| Joseph P. Mitchell | M | 55 |
The University of Alabama
| 4 years |
| Scott Flurry | M | - |
The University of Alabama
| 4 years |
| Philip A. Patterson | M | - |
The University of Alabama
| 2 years |
| James E. Ankrum | M | - |
The University of Alabama
| 1 years |
| Thomas Joel Wann | M | - |
The University of Alabama
| 4 years |
| Christopher T. Bell | M | - |
The University of Alabama
| 1 years |
| Bill Bolen | M | - |
The University of Alabama
| 4 years |
| Douglas Luckett | M | - |
The University of Alabama
| 4 years |
| Zach Musso | M | - |
The University of Alabama
| 4 years |
| Charles Reinhart | M | 63 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 79 | 79.00% |
| Serbia, Republic of | 18 | 18.00% |
| Ireland | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Srdjan Stankovic
- Personal Network
